These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6236244)

  • 41. Sleep and 5-HT2 receptor sensitivity in recovered depressed patients.
    da Roza Davis JM; Sharpley AL; Solomon RA; Cowen PJ
    J Affect Disord; 1992 Mar; 24(3):177-81. PubMed ID: 1573126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Further characterization of the inhibition of platelet aggregation by a plasma factor(s) in unmedicated unipolar depressed patients.
    Nugent DF; Dinan TG; Leonard BE
    J Affect Disord; 1995 Apr; 33(4):227-31. PubMed ID: 7790676
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute tryptophan depletion: a method of studying antidepressant action.
    Miller HL; Delgado PL; Salomon RM; Licinio J; Barr LC; Charney DS
    J Clin Psychiatry; 1992 Oct; 53 Suppl():28-35. PubMed ID: 1429482
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical data on the role of serotonin in the mechanism(s) of action of antidepressant drugs.
    Price LH; Charney DS; Delgado PL; Goodman WK; Krystal JH; Woods SW; Heninger GR
    J Clin Psychiatry; 1990 Apr; 51 Suppl():44-50; discussion 51-2. PubMed ID: 2182616
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
    Moulignier A
    Rev Neurol (Paris); 1994; 150(1):3-15. PubMed ID: 7801037
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of the alpha(2A)-adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro.
    Maayani S; Schwarz T; Craddock-Royal B; Tagliente TM
    Platelets; 2001 Sep; 12(6):359-75. PubMed ID: 11672475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Studies with new ergoline derivatives on the effects of central and peripheral 5-hydroxytryptamine receptors.
    Harhammer R; Schäfer U; Ott T
    Arzneimittelforschung; 1992 Oct; 42(10):1175-9. PubMed ID: 1472137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potentiation of ADP-induced aggregation in human platelet-rich plasma by 5-hydroxytryptamine and adrenaline.
    Vanags DM; Rodgers SE; Duncan EM; Lloyd JV; Bochner F
    Br J Pharmacol; 1992 Aug; 106(4):917-23. PubMed ID: 1393289
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serotonergic aspects of the response of human platelets to immune-adjuvant muramyl dipeptide.
    Polanski M; Karnovsky ML
    J Neuroimmunol; 1992 Mar; 37(1-2):149-60. PubMed ID: 1532180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Further studies on platelet serotonin transporter binding in depression.
    Nemeroff CB; Knight DL; Franks J; Craighead WE; Krishnan KR
    Am J Psychiatry; 1994 Nov; 151(11):1623-5. PubMed ID: 7943450
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence for the 5-HT hypothesis of suicide. A review of post-mortem studies.
    Mann JJ; Arango V; Marzuk PM; Theccanat S; Reis DJ
    Br J Psychiatry Suppl; 1989 Dec; (8):7-14. PubMed ID: 2692642
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Mechanism of action of antidepressants].
    Llorca PM; Reine G; Wolf MA
    Can J Psychiatry; 1993 Dec; 38(10):649-56. PubMed ID: 8313303
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of a selective 5HT1-receptor agonist GR43175 on platelet responsiveness.
    Tozzi-Ciancarelli MG; Di Massimo C; Tozzi E; Mascioli A; De Matteis G; Carolei A
    Cephalalgia; 1995 Dec; 15(6):472-36. PubMed ID: 8706109
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Behavioral indications for serotonin receptor hypersensitivity in panic disorder.
    Kahn RS; Wetzler S; van Praag HM; Asnis GM; Strauman T
    Psychiatry Res; 1988 Jul; 25(1):101-4. PubMed ID: 3217461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Platelet 5-HT receptor binding during depressive illness and tricyclic antidepressant treatment.
    Cowen PJ; Charig EM; Fraser S; Elliott JM
    J Affect Disord; 1987; 13(1):45-50. PubMed ID: 2959699
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serotonin receptor site in human platelets from control and chlorpromazine treated subjects.
    Oppenheim B; Hefez A; Youdim MB
    Prog Biochem Pharmacol; 1980; 16():119-32. PubMed ID: 7443729
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression.
    Siever LJ; Murphy DL; Slater S; de la Vega E; Lipper S
    Life Sci; 1984 Mar; 34(11):1029-39. PubMed ID: 6700367
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects.
    Heninger GR; Charney DS; Sternberg DE
    Arch Gen Psychiatry; 1984 Apr; 41(4):398-402. PubMed ID: 6703856
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A paradox: the 5-HT2-receptor antagonist ketanserin restores the 5-HT-induced contraction depressed by methysergide in large coronary arteries of calf. Allosteric regulation of 5-HT2-receptors.
    Kaumann AJ; Frenken M
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):295-300. PubMed ID: 3157064
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serotonin-induced platelet aggregation predicts the antihypertensive response to serotonin receptor antagonists.
    Gleerup G; Persson B; Hedner T; Winther K
    Eur J Clin Pharmacol; 1993; 44(2):121-5. PubMed ID: 8453957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.